WO2023031738 - NOVEL MTOR INHIBITOR COMPOUNDS
National phase entry:
Publication Number
WO/2023/031738
Publication Date
09.03.2023
International Application No.
PCT/IB2022/057943
International Filing Date
24.08.2022
Title **
[English]
NOVEL MTOR INHIBITOR COMPOUNDS
[French]
NOUVEAUX COMPOSÉS INHIBITEURS DE MTOR
Applicants **
GALDERMA HOLDING SA
Zählerweg 10
6300 Zug, CH
Inventors
HARRIS, Craig Steven
42 Chemin de Santa Maria
06410 Biot, FR
VIAL, Emmanuel
5 boulevard du général Leclerc
06480 La Colle sur Loup, FR
ZANELLI, Ugo
Lungarno Buozzi n.20
56127 Pisa (I), IT
Priority Data
63/239,353
31.08.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1616 | |
| EPO | Filing, Examination | 9792 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 6310 |
Total: 18884 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
Novel compounds having formula (I) and methods of using these compounds to treat diseases, conditions, and disorders are described. (I)[French]
L'invention concerne de nouveaux composés de formule (I) et des procédés d'utilisation de ces composés pour traiter des maladies, des états et des troubles. (I)